Tirzepatide for Prostate Cancer

Recruiting in Palo Alto (17 mi)

Overseen byJustin Gregg, MD

Age: 18+

Sex: Male

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Phase < 1

Waitlist Available

Sponsor: M.D. Anderson Cancer Center

No Placebo Group

Trial Summary

What is the purpose of this trial?The goal of this clinical research study is to determine how well a tirzepatide-assisted weight loss program works before a prostatectomy in patients with intermediate risk prostate cancer

Eligibility Criteria

This trial is for men who have both diabetes and intermediate-risk prostate cancer, are scheduled for a prostatectomy (surgery to remove the prostate), and need to lose weight before surgery. Specific details about eligibility criteria were not provided.

Inclusion Criteria

My prostate cancer is confirmed, localized, and considered intermediate risk.

My BMI is 27 or higher, or my waist is over 40 inches.

I am willing and able to follow the study's procedures and self-inject medication.

+3 more

Exclusion Criteria

I have had treatments like hormone therapy, chemo, surgery, or radiation for prostate cancer.

I have a history of pancreatitis.

I haven't had severe depression or serious mental health issues in the last 2 years.

+16 more

Participant Groups

The study is testing whether Tirzepatide can help these patients lose weight effectively before their surgery. It's a pilot feasibility study, which means it's an early test to see if this approach could work well.

1Treatment groups

Experimental Treatment

Group I: TirzepatideExperimental Treatment1 Intervention